abstract |
The present invention provides novel purine and imidazopyridine derivatives useful for the prevention and treatment of autoimmune diseases, inflammatory diseases, mast cell dependent diseases, and graft rejection. The compounds of the present application are compounds of general formulas (I) and (II). |